Back to OGNView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
Drug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
MK0663, Etoricoxib / Duration of Treatment : 12 WeeksPhase 3
Recurrent Low Back Pain
MK0217, alendronate sodium / Duration of Treatment : 2 YearsPhase 3
Osteoporosis, Postmenopausal
Tibolone 2.5 mgPhase 3
Postmenopausal Women
Corifollitropin alfaPhase 3
In Vitro Fertilization
A-Phase: tirofiban; Z-Phase simvastatinPhase 3
Acute Coronary Syndrome
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts